3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
21
Recruiting
11
Terminated
9
Unknown
7
Active not recruiting
2
Withdrawn
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
14
Other solid neoplasm
14
Sarcoma
1
Other neoplasm
1
Myeloid
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
158
Pancreatic Neoplasms
148
Carcinoma, Hepatocellular
127
Colonic Neoplasms
79
Stomach Neoplasms
58
Rectal Neoplasms
58
Liver Neoplasms
47
Esophageal Neoplasms
46
Breast Neoplasms
40
Neoplasms
36
Neoplasm Metastasis
35
Cholangiocarcinoma
32
Lung Neoplasms
23
Gastrointestinal Neoplasms
20
Ovarian Neoplasms
17
Biliary Tract Neoplasms
15
Carcinoma, Non-Small-Cell Lung
14
Esophageal Squamous Cell Carcinoma
13
Uterine Cervical Neoplasms
11
Gallbladder Neoplasms
10
Adenocarcinoma
10
Sarcoma
9
Carcinoma, Renal Cell
9
Adenocarcinoma Of Esophagus
9
Urinary Bladder Neoplasms
8
Recurrence
8
Bile Duct Neoplasms
8
Prostatic Neoplasms
7
Gastrointestinal Stromal Tumors
7
Colonic Polyps
7
Interventions
tislelizumab
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Mesothelioma, Malignant
×
Gastrointestinal
×
Clear all
NCT05582031
2023-06-07
REFIT-MSS
Translational Research in Oncology
Phase 2
Withdrawn